Linical was started by a group of entrepreneurs at a major Japanese pharmaceutical company, in 2005. It is a mid-sized, public, Contract Research Organization (CRO) with headquarters in Japan, and a substantial presence across, Europe, North America, and Asia-Pacific. It offers a full range of drug development services from early phase to large-scale, worldwide studies. Its areas of focus include Stage I-IV studies in infectious disease, oncology, and CNS. It provides its clients with the flexibility, individual attention, and reach needed for a constantly evolving biotech and pharmaceutical market. It believes in helping clients during their unique clinical development journey, with a mutual goal of bringing hopeful new therapies to patients all over the world. Its vision is to be the Contract Research Organization (CRO) of preference among the global and mid-sized CRO market.
